Form 4: Myomo Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Harry Kovelman, Chief Medical Officer of Myomo, Inc., sold 5,347 shares of common stock on June 10, 2024, to cover income taxes resulting from vesting of restricted stock units.
Summary
- Harry Kovelman, the Chief Medical Officer of Myomo, Inc., sold 5,347 shares of common stock on June 10, 2024.
- The sale was executed to cover income taxes resulting from the vesting of restricted stock units on June 8 and June 9, 2024.
- The shares were sold at an average price of $3.379, with individual sales ranging from $3.33 to $3.39 per share.
- Following the transaction, Kovelman directly owns 145,541 shares of Myomo, Inc.
- The sale was conducted pursuant to an irrevocable election made by Kovelman on May 12, 2024.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (stock sale for tax purposes) and doesn't inherently indicate positive or negative sentiment.
Industry Context
Executive stock sales are a common occurrence, often related to compensation and tax planning. Monitoring these transactions can provide insights into management's perspective on the company's value.
Stakeholder Impact
- The stock sale could have a minor impact on shareholders due to the increased supply of shares, but the effect is likely minimal given the relatively small number of shares sold.
Key Dates
| Date | Description |
|---|---|
| May 12, 2024 | Reporting Party made an irrevocable election. |
| June 8, 2024 | Vesting of multiple restricted stock unit grants. |
| June 9, 2024 | Vesting of multiple restricted stock unit grants. |
| June 10, 2024 | Date of transaction (stock sale). |
| June 12, 2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.